(Q50804094)

English

Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.

scientific article published on 4 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Claudio Jeldres

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Alberto Briganti

8

object named as

Alberto Briganti

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

Pierre I Karakiewicz

13

object named as

Pierre I Karakiewicz

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

3

object named as

Paul Perrotte

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

12

object named as

Fred Saad

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Jean-Pierre Guay

11

object named as

Jean-Pierre Guay

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

François Bénard

6

object named as

Francois Benard

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

author name string

Georg C Hutterer

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Luc Valiquette

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Michael McCormack

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Constantin Ionescu

9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

publication date

4 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

100

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

37-41

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

Prostate cancers in men with low PSA levels--must we find them?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Prostate cancer detection at low prostate specific antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Age-specific reference ranges for serum prostate-specific antigen in black men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06923.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2007.06923.X

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17488305

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50804094&oldid=1739661083"